ATAI Life Sciences BV (ATAI) — Capital Reinvestment Ratio

Latest as of June 2021: 0.15x

ATAI Life Sciences BV (ATAI) has a Capital Reinvestment Ratio of 0.15x as of June 2021, meaning it reinvests 0% of its operating cash flow ($1.90 Million) in capital expenditures ($278.00K). See ATAI net asset quality score to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.15x

Capex / Operating Cash Flow

Operating Cash Flow

$1.90 Million

USD

Capital Expenditures

$278.00K

USD

Data as of

Jun 2021

Most recent filing

Annual Capital Reinvestment Ratio for ATAI Life Sciences BV (None–None)

Year-by-year Capital Reinvestment Ratio for ATAI Life Sciences BV from None to None. For live market cap and broader valuation context, see ATAI Life Sciences BV market cap and net worth.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow